InEdita Bio
PrivateLast Round
Grant
Aug 4, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
InEdita Bio operates in Healthcare & Life Sciences and is based in the United States. Its latest recorded funding round was a Grant round in August 2025.
InEdita Bio is an agricultural biotechnology company that develops a proprietary genome editing platform using CRISPR technology to create non-transgenic crops with enhanced resistance to pests, diseases, and environmental stressors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InEdita Bio Comparables
Compare InEdita Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cibus, Inc. | 83% | |
| Phytoform Labs | 83% | |
| Hudson River Biotechnology | 82% |
For institutional investors. Book with your work email.
InEdita Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 4, 2025 | ||||
| Seed | Aug 20, 2023 |
For institutional investors. Book with your work email.
InEdita Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Financiadora de Estudos e Projetos | Grant |
| Ecoa Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 72% MoM.
- May 8, 2026
Grew 25% QoQ, from 12 to 15 employees.
For institutional investors. Book with your work email.
InEdita Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about InEdita Bio's valuation, stock price, and market status.
Is InEdita Bio a public or private company?
InEdita Bio is a private company.
What is the current stock price of InEdita Bio?
InEdita Bio is a private company, so its shares have no public market price. Caplight tracks InEdita Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is InEdita Bio worth (valuation)?
Valuation information for InEdita Bio is not publicly available.
Can I buy InEdita Bio stock?
InEdita Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was InEdita Bio's last funding round?
InEdita Bio's most recent funding round was Grant on August 4, 2025.
Who are the main investors in InEdita Bio?
Key investors in InEdita Bio include Financiadora de Estudos e Projetos, Ecoa Capital.
Will InEdita Bio IPO soon?
No public IPO plans have been announced for InEdita Bio.
How can I track InEdita Bio secondary market activity?
Caplight tracks bids, offers, and trades in InEdita Bio's shares on secondary markets.